Koninklijke Philips (RYLPF) EPS (Weighted Average and Diluted) (2017 - 2018)
Koninklijke Philips (RYLPF) recorded quarterly EPS (Weighted Average and Diluted) of $0.0 in Q1 2018, down 99.79% quarter-over-quarter from $0.52 in Q1 2017, and down 99.79% on a YoY basis from $0.52 in Q1 2017.
Koninklijke Philips (RYLPF) EPS (Weighted Average and Diluted) (2017 - 2018) Analysis & Trends
Koninklijke Philips' EPS (Weighted Average and Diluted) history runs 2 years deep, the most recent figure standing at $0.0 for Q1 2018.
- In Q1 2018, EPS (Weighted Average and Diluted) fell 99.79% year-over-year to $0.0; the TTM figure through Mar 2018 stood at $0.0 (down 99.79% YoY), while the FY2025 annual figure was $1.08, up 235.08% from the prior year.
- EPS (Weighted Average and Diluted) was $0.0 for Q1 2018 at Koninklijke Philips, down from $0.52 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.52 in Q1 2017 to a low of $0.0 in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 2.24 |
| 10 | Koninklijke Philips | - | - | 2.07 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 0.00 |
| Mar 31, 2017 | 0.52 |